PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

China · Delayed Price · Currency is CNY

41.14

+0.99 (2.47%)

Feb 3, 2026, 3:04 PM CST

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Drug Development and Manufacturing Services (Contract Development and Manufacturing Organization)	863.40M
Drug Development and Manufacturing Services (Contract Development and Manufacturing Organization) Growth	3.38%
Molecular Building Blocks (for Drug Development and Production)	490.89M
Molecular Building Blocks (for Drug Development and Production) Growth	-9.82%
Molecular Building Blocks (for Drug Discovery)	280.73M
Molecular Building Blocks (for Drug Discovery) Growth	-12.67%
Chemical Research and Development (Chemical Research Organization)	50.51M
Chemical Research and Development (Chemical Research Organization) Growth	112.16%
Other	3.10M
Other Growth	585.95%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Abroad	1.24B
Abroad Growth	4.94%
China	448.70M
China Growth	-17.47%